MEDNAX (MD) Tops Q2 EPS by 3c

MEDNAX (NYSE: MD) reported Q2 EPS of $0.34, $0.03 better than the analyst estimate of $0.31. Revenue for the quarter came in at $504 million versus the consensus estimate of $505.49 million.

For earnings history and earnings-related data on MEDNAX (MD) click here.

You May Also Be Interested In

• IDT Corp. (IDT) Tops Q3 EPS by 2c; offer guidance
• RBC Capital on Veeva Systems (VEEV) Amid After Hours Selloff on Earnings: 'we are surprised to see shares trade down'
• Genco Shipping urges shareholders to reject Diana's $24.80 takeover bid